632 Participants Needed

CO2 Detector for Neonatal Resuscitation

(CO2-Vent Trial)

RC
Overseen ByRiti Chokshi, MD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: University of Texas Southwestern Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I need to stop my current medications for this trial?

The trial does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment Pedi-Cap CO2 Detector for neonatal resuscitation?

Research shows that the Pedi-Cap CO2 Detector is effective in confirming the correct placement of breathing tubes in newborns and can indicate an increase in heart rate during resuscitation, which is a key sign of improved infant well-being.12345

Is the CO2 detector safe for use in newborns?

The CO2 detectors, including the Pedi-Cap, have been used safely in newborns to help confirm proper placement of breathing tubes during resuscitation. They are considered valuable tools for managing airways in newborns, especially during emergencies.12356

How does the CO2 detector treatment for neonatal resuscitation differ from other treatments?

The CO2 detector treatment for neonatal resuscitation is unique because it uses a colorimetric carbon dioxide detector to confirm proper airway placement and effective ventilation by changing color when exposed to exhaled CO2. This provides immediate visual feedback, which is not available with traditional methods, helping ensure that newborns receive adequate ventilation during resuscitation.12367

What is the purpose of this trial?

The goal of this study is to determine if using a Pedi-Cap (a type of colorimetric carbon dioxide detector) during face mask ventilation (PPV) for newborn infants in the delivery room will lower the time of PPV needed. A group of nurses, doctors, and respiratory therapists, called the neonatal resuscitation team, will either use or not use the Pedi-Cap during face mask PPV for infants born at ≥30 weeks' gestation.A randomization generator will assign each month to either use the Pedi-Cap or not use the Pedi-Cap. The researchers will collect information from the medical chart to find the infant and mother's information, medical interventions done in the delivery room, and lab values. In addition, resuscitation team members will fill out a survey of their experiences of using or not using the Pedi-Cap during delivery room facemask PPV.

Research Team

RC

Riti Chokshi

Principal Investigator

University of Texas

Eligibility Criteria

This trial is for newborn infants born at or after 30 weeks' gestation who need non-invasive positive pressure ventilation (PPV) in the delivery room. The neonatal resuscitation team must be present before delivery to participate.

Inclusion Criteria

A resuscitation team must be present before delivery.
My baby was born at or after 30 weeks of pregnancy.
I require a machine to help me breathe.

Exclusion Criteria

My infant needs immediate breathing support due to a birth defect.
No non-invasive PPV needed in the delivery room
Infants who have a prenatal plan of comfort care only
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Neonatal resuscitation team uses or does not use the Pedi-Cap during face mask PPV for infants born at ≥30 weeks' gestation in the delivery room

Approximately 1 hour of life
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of mechanical ventilation duration and need for NICU admission

Up to 50 weeks

Survey

Resuscitation team members complete a survey to assess their experience with each study arm

Treatment Details

Interventions

  • Pedi-Cap
Trial Overview The study tests if using a Pedi-Cap, which detects carbon dioxide, can reduce the time newborns need face mask PPV in the delivery room. Infants are randomly assigned monthly to either use or not use the Pedi-Cap during PPV.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Pedi-CapExperimental Treatment1 Intervention
A Pedi-Cap will be connected to the T-piece resuscitator in between the T-piece and face mask. With effective gas exchange, carbon dioxide (CO2) is detected by the Pedi-cap and will demonstrate gold color change with each exhalation. If there is no CO2 gas exchanged, the Pedi-Cap color will remain purple. The color change will be used as one of the tools for the resuscitation team to determine if the infant has effective non-invasive positive pressure ventilation (PPV) during delivery room resuscitation. Other ways, in addition to the Pedi-Cap, to determine effective PPV include a rise in heart rate, improved infant color, chest rise, and improvement in oxygen saturation.
Group II: No Pedi-CapActive Control1 Intervention
There will be no Pedi-Cap attached to the t-piece resuscitator. Effective non-invasive positive pressure ventilation (PPV) during delivery room resuscitation will be assessed by a rise in heart rate, improved infant color, chest rise, and improvement in oxygen saturation.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Texas Southwestern Medical Center

Lead Sponsor

Trials
1,102
Recruited
1,077,000+

Findings from Research

The Pedi-CAP disposable ETCO2 detector demonstrated high accuracy in verifying endotracheal tube placement in newborns, with a sensitivity of 91% and specificity of 100%, making it a reliable tool for neonatal resuscitation.
Using the Pedi-CAP significantly reduced the time needed to confirm proper tube placement to an average of 8.1 seconds, compared to 39.7 seconds with clinical evaluation, which is crucial for quickly identifying and correcting misplacements, especially in vulnerable infants.
The pediatric disposable end-tidal carbon dioxide detector role in endotracheal intubation in newborns.Aziz, HF., Martin, JB., Moore, JJ.[2019]
Using a CO2 detector during manual ventilation significantly improves the effectiveness of positive pressure ventilation in neonatal resuscitation, especially within the first minute, with effective ventilation rates of 90% for T-piece alone, 94% for Pedi-Cap, and 96% for Neo-Stat.
Among 19 pediatric trainees who performed a total of 7,790 ventilations, the Neo-Stat CO2 detector was preferred by two-thirds of the participants, indicating a strong preference for this device in clinical practice.
Efficacy and user preference of two CO2 detectors in an infant mannequin randomized crossover trial.Hawkes, GA., O'Connell, BJ., Livingstone, V., et al.[2021]
In a study of 41 newborns with bradycardia receiving mask ventilation, the Pedi-Cap's color change indicating CO₂ levels preceded a significant increase in heart rate, demonstrating its potential as an early indicator of improved respiratory function during neonatal resuscitation.
The use of the Pedi-Cap not only provided immediate feedback on CO₂ levels but also correlated with increased oxygen saturation, making it a valuable, electricity-free tool for neonatal resuscitation, particularly in resource-limited settings.
Pedi-cap color change precedes a significant increase in heart rate during neonatal resuscitation.Blank, D., Rich, W., Leone, T., et al.[2022]

References

The pediatric disposable end-tidal carbon dioxide detector role in endotracheal intubation in newborns. [2019]
Efficacy and user preference of two CO2 detectors in an infant mannequin randomized crossover trial. [2021]
Pedi-cap color change precedes a significant increase in heart rate during neonatal resuscitation. [2022]
Verification of endotracheal tube placement with colorimetric end-tidal CO2 detection. [2022]
Are carbon dioxide detectors useful in neonates? [2018]
Tidal volume threshold for colorimetric carbon dioxide detectors available for use in neonates. [2013]
Disposable colorimetric carbon dioxide detector use as an indicator of a patent airway during noninvasive mask ventilation. [2013]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security